JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 18, 2005; DOI: 10.1124/jpet.105.092171


0022-3565/06/3162-709-717$20.00
JPET 316:709-717, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.092171v1
316/2/709    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, R.-J.
Right arrow Articles by Chen, I.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, R.-J.
Right arrow Articles by Chen, I.-J.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

A Xanthine-Based Epithelium-Dependent Airway Relaxant KMUP-3 (7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) Increases Respiratory Performance and Protects against Tumor Necrosis Factor-{alpha}-Induced Tracheal Contraction, Involving Nitric Oxide Release and Expression of cGMP and Protein Kinase G

Rong-Jyh Lin, Bin-Nan Wu, Yi-Ching Lo, Li-Mei An, Zen-Kong Dai, Young-Tso Lin, Chao-Shun Tang, and Ing-Jun Chen

Institute of Medicine (R.-J.L.), Department and Graduate Institute of Pharmacology (B.-N.W., Y.-C.L., L.-M.A., I.-J.C.), and Departments of Pediatrics (Z.-K.D.), Cardiovascular Surgery (Y.-T.L.), and Anesthesiology (C.-S.T.), College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) was investigated in guinea pig tracheal smooth muscle. Intratracheal instillation of tumor necrosis factor (TNF)-{alpha} (0.01 mg/kg/300 µl) induced bronchoconstriction, increases of lung resistance, and decreases of dynamic lung compliance. Instillation of KMUP-3 (0.5-2.0 mg/kg) reversed this situation. In isolated trachea precontracted with carbachol, KMUP-3 (10-100 µM)-caused relaxations were attenuated by epithelium removal and by pretreatments with an inhibitor of K+ channel, tetraethylammonium (10 mM); KATP channel, glibenclamide (1 µM); voltage-dependent K+ channel, 4-aminopyridine (100 µM); Ca2+-dependent K+ channel, charybdotoxin (0.1 µM) or apamin (1 µM); soluble guanylate cyclase (sGC), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1one (ODQ, 1 µM); nitric-oxide (NO) synthase, N{omega}-nitro-L-arginine methyl ester (L-NAME, 100 µM); and adenylate cyclase, SQ 22536 [9-(terahydro-2-furanyl)-9H-purin-6-amine] (100 µM). KMUP-3 (0.01-100 µM) induced increases of cGMP and cAMP in primary culture of tracheal smooth muscle cells (TSMCs). The increase in cGMP by KMUP-3 was reduced by ODQ and L-NAME; the increase in cAMP was reduced by SQ 22536. Western blot analysis indicated that KMUP-3 (1 µM) induced expression of protein kinase A (PKA)ri and protein kinase G (PKG)1{alpha} 1beta in TSMCs.SQ 22536 inhibited KMUP-3-induced expression of (PKA)ri.On the contrary, ODQ inhibited KMUP-3-induced expression of PKG1{alpha} 1beta In epithelium-intact trachea, KMUP-3 increased the NO release. Activation of sGC, NO release, and inhibition of phosphodiesterases in TSMCs by KMUP-3 may result in increases of intracellular cGMP and cAMP, which subsequently activate PKG and PKA, efflux of K+ ion, and associated reduction in Ca2+ influx in vitro, indicating the action mechanism to protect against TNF-{alpha}-induced airway dysfunction in vivo.


Received for publication July 7, 2005
Accepted October 14, 2005.

Address correspondence to: Dr. Ing-Jun Chen, Department and Graduate Institute of Pharmacology, College of Medicine, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan. E-mail: ingjun{at}kmu.edu.tw




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B.-N. Wu, C.-W. Chen, S.-F. Liou, J.-L. Yeh, H.-H. Chung, and I.-J. Chen
Inhibition of Proinflammatory Tumor Necrosis Factor-{alpha}-Induced Inducible Nitric-Oxide Synthase by Xanthine-Based 7-[2-[4-(2-Chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in Rat Trachea: The Involvement of Soluble Guanylate Cyclase and Protein Kinase G
Mol. Pharmacol., September 1, 2006; 70(3): 977 - 985.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.